申请人:Allergan Sales, Inc.
公开号:US06147224A1
公开(公告)日:2000-11-14
Compounds of Formula 1, Formula 2 or Formula 3 where X is O, S, or (CR.sub.1 R.sub.1).sub.n where n is 0, 1 or 2; Y is a bivalent radical having Formula 4 or Formula 5 where o is an integer from 1 to 4 ##STR1## or Y is a bivalent aryl or 5 or 6 membered heteroaryl radical having 1 to 3 heteroatoms selected from N, S and O, said aryl or heteroaryl groups being unsubstituted, or substituted with 1 to 3 C.sub.1-6 alkyl or with 1 to 3 C.sub.1-6 fluoroalkyl groups; and the remaining symbols have the meaning described in the specification, have RXR selective retinoid agonist-like activity.
具有Formula 1、Formula 2或Formula 3的化合物,其中X为O、S或(CR.sub.1 R.sub.1).sub.n,其中n为0、1或2;Y为具有Formula 4或Formula 5的二价基团,其中o为1到4的整数,或者Y为具有1到3个异氮、硫和氧的杂原子的二价芳基或5或6成员杂芳基基团,所述芳基或杂芳基基团未取代,或者与1到3个C.sub.1-6烷基或1到3个C.sub.1-6氟烷基基团取代;其余符号具有规范中描述的含义,具有RXR选择性视黄醇激动剂样活性。